These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1994 related articles for article (PubMed ID: 16456071)

  • 1. Toxic potential of materials at the nanolevel.
    Nel A; Xia T; Mädler L; Li N
    Science; 2006 Feb; 311(5761):622-7. PubMed ID: 16456071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current methods and research progress in nanomaterials risk assessment.
    Lin H; Bu Q; Cen X; Zhao YL
    Curr Drug Metab; 2012 May; 13(4):354-63. PubMed ID: 22443532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems.
    Shvedova AA; Kagan VE; Fadeel B
    Annu Rev Pharmacol Toxicol; 2010; 50():63-88. PubMed ID: 20055698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
    Lai DY
    Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't define nanomaterials.
    Maynard AD
    Nature; 2011 Jul; 475(7354):31. PubMed ID: 21734686
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity testing of nanomaterials.
    Schrand AM; Dai L; Schlager JJ; Hussain SM
    Adv Exp Med Biol; 2012; 745():58-75. PubMed ID: 22437813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of engineered nanomaterials and nanotechnologies--a review.
    Savolainen K; Alenius H; Norppa H; Pylkkänen L; Tuomi T; Kasper G
    Toxicology; 2010 Mar; 269(2-3):92-104. PubMed ID: 20105448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
    Hirose A; Nishimura T; Kanno J
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure assessment approaches for engineered nanomaterials.
    Abbott LC; Maynard AD
    Risk Anal; 2010 Nov; 30(11):1634-44. PubMed ID: 20626687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health risks of engineered nanomaterials and nanotechnologies].
    Savolainen K; Vainio H
    Duodecim; 2011; 127(11):1097-104. PubMed ID: 21755801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the occupational, consumer and environmental exposure to engineered nanomaterials used in 10 technology sectors.
    Nowack B; Brouwer C; Geertsma RE; Heugens EH; Ross BL; Toufektsian MC; Wijnhoven SW; Aitken RJ
    Nanotoxicology; 2013 Sep; 7(6):1152-6. PubMed ID: 22783888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold Nanomaterials in Consumer Cosmetics Nanoproducts: Analyses, Characterization, and Dermal Safety Assessment.
    Cao M; Li J; Tang J; Chen C; Zhao Y
    Small; 2016 Oct; 12(39):5488-5496. PubMed ID: 27562146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health and safety implications of occupational exposure to engineered nanomaterials.
    Stebounova LV; Morgan H; Grassian VH; Brenner S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(3):310-21. PubMed ID: 22131295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological interactions and toxicity of nanomaterials in the respiratory tract and various approaches of aerosol generation for toxicity testing.
    Creutzenberg O
    Arch Toxicol; 2012 Jul; 86(7):1117-22. PubMed ID: 22418596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical properties of nanomaterials: implication in associated toxic manifestations.
    Gatoo MA; Naseem S; Arfat MY; Dar AM; Qasim K; Zubair S
    Biomed Res Int; 2014; 2014():498420. PubMed ID: 25165707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.
    Murdock RC; Braydich-Stolle L; Schrand AM; Schlager JJ; Hussain SM
    Toxicol Sci; 2008 Feb; 101(2):239-53. PubMed ID: 17872897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies.
    Klein CL; Wiench K; Wiemann M; Ma-Hock L; van Ravenzwaay B; Landsiedel R
    Arch Toxicol; 2012 Jul; 86(7):1137-51. PubMed ID: 22532024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.
    Borm P; Klaessig FC; Landry TD; Moudgil B; Pauluhn J; Thomas K; Trottier R; Wood S
    Toxicol Sci; 2006 Mar; 90(1):23-32. PubMed ID: 16396841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.